Bafna Pharmaceuticals Ltd.
•₹ 242.452%
2026-08-21
PROS
- Company has delivered good sales growth of 28.0% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.60x)
- Company maintains a comfortable, low leverage position
CONS
- A large part of profit comes from other income (73.3% of PBT)
- Promoter holding has decreased over last 2 years: -13.3pp
- Recent results are weak - TTM profit is down 13.8% versus prior year
- Company has a low return on capital employed of 10.7%
- Effective tax rate is unusually low at 0.0% - earnings may be flattered
- Operating margins have contracted to 7.5% from 16.0%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | BAFNAPH | 247.10 | 0.00 | 584.55 | 0.00 | 6.04 | — | 131.33 | — | 6.31 | 32.32 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42 | 41 | 28 | 41 | 33 | 40 | 33 | 39 | 35 | 35 | 38 | 42 | 27 | |
| 36 | 37 | 31 | 39 | 32 | 37 | 30 | 36 | 30 | 31 | 35 | 39 | 28 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 2 | 2 | 2 |
| 6 | 2 | -3 | 1 | -1 | 3 | 1 | 1 | 3 | 3 | 2 | 3 | 0 | |
| Tax % | 0.00% | 0.00% | -0.00% | 0.00% | -0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -4.96% | 0.00% |
| Net Profit | 6 | 2 | -3 | 1 | -1 | 3 | 1 | 1 | 3 | 3 | 2 | 3 | 0 |
| 3 | 1 | -1 | 1 | -0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | |
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 42
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 1
- 6
- Tax %
- 0.00%
- Net Profit
- 6
- 3
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 41
- 37
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 2
- Tax %
- 0.00%
- Net Profit
- 2
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 28
- 31
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- -3
- Tax %
- -0.00%
- Net Profit
- -3
- -1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 41
- 39
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 33
- 32
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- -1
- Tax %
- -0.00%
- Net Profit
- -1
- -0
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 40
- 37
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 0.00%
- Net Profit
- 3
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 33
- 30
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 39
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 35
- 30
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 3
- Tax %
- 0.00%
- Net Profit
- 3
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 35
- 31
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 3
- Tax %
- 0.00%
- Net Profit
- 3
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 38
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 0.00%
- Net Profit
- 2
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 42
- 39
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- -4.96%
- Net Profit
- 3
- 1
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 27
- 28
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 2
- 0
- Tax %
- 0.00%
- Net Profit
- 0
- 0
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 24
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 85 | 65 | 47 | 44 | 42 | 71 | 85 | 115 | 152 | 146 | 143 | |
| 83 | 70 | 82 | 57 | 41 | 61 | 73 | 100 | 141 | 135 | 134 | |
| Operating Profit | 4 | -4 | -4 | -13 | 1 | 11 | 14 | 19 | 15 | 14 | — |
| OPM % | 5 | -6 | -8 | -29 | 3 | 16 | 16 | 16 | 10 | 10 | — |
| Other Income | 1 | 1 | 31 | 0 | 0 | 1 | 2 | 3 | 4 | 3 | 6 |
| Interest | 12 | 11 | 7 | 2 | 0 | 1 | 1 | 2 | 2 | 3 | 4 |
| Depreciation | 4 | 4 | 4 | 3 | 3 | 4 | 5 | 5 | 5 | 5 | 6 |
| -13 | -19 | -14 | -18 | -2 | 6 | 5 | 12 | 7 | 4 | 8 | |
| Tax % | 3 | 4 | -15 | -8 | 0 | 0 | 0 | 2 | 0 | 0 | -2 |
| Net Profit | -12 | -18 | -16 | -20 | -2 | 6 | 5 | 11 | 7 | 4 | 8 |
| EPS | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 5 | 3 | 2 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -7 | -10 | -7 | -8 | -8 | 2 | 2 | 5 | 3 | 2 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -7 | -10 | -7 | -8 | -8 | 2 | 2 | 5 | 3 | 2 | — |
Mar 2016
- 85
- 83
- Operating Profit
- 4
- OPM %
- 5
- Other Income
- 1
- Interest
- 12
- Depreciation
- 4
- -13
- Tax %
- 3
- Net Profit
- -12
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
Mar 2017
- 65
- 70
- Operating Profit
- -4
- OPM %
- -6
- Other Income
- 1
- Interest
- 11
- Depreciation
- 4
- -19
- Tax %
- 4
- Net Profit
- -18
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
Mar 2018
- 47
- 82
- Operating Profit
- -4
- OPM %
- -8
- Other Income
- 31
- Interest
- 7
- Depreciation
- 4
- -14
- Tax %
- -15
- Net Profit
- -16
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
Mar 2019
- 44
- 57
- Operating Profit
- -13
- OPM %
- -29
- Other Income
- 0
- Interest
- 2
- Depreciation
- 3
- -18
- Tax %
- -8
- Net Profit
- -20
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2020
- 42
- 41
- Operating Profit
- 1
- OPM %
- 3
- Other Income
- 0
- Interest
- 0
- Depreciation
- 3
- -2
- Tax %
- 0
- Net Profit
- -2
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2021
- 71
- 61
- Operating Profit
- 11
- OPM %
- 16
- Other Income
- 1
- Interest
- 1
- Depreciation
- 4
- 6
- Tax %
- 0
- Net Profit
- 6
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2022
- 85
- 73
- Operating Profit
- 14
- OPM %
- 16
- Other Income
- 2
- Interest
- 1
- Depreciation
- 5
- 5
- Tax %
- 0
- Net Profit
- 5
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2023
- 115
- 100
- Operating Profit
- 19
- OPM %
- 16
- Other Income
- 3
- Interest
- 2
- Depreciation
- 5
- 12
- Tax %
- 2
- Net Profit
- 11
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 152
- 141
- Operating Profit
- 15
- OPM %
- 10
- Other Income
- 4
- Interest
- 2
- Depreciation
- 5
- 7
- Tax %
- 0
- Net Profit
- 7
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 146
- 135
- Operating Profit
- 14
- OPM %
- 10
- Other Income
- 3
- Interest
- 3
- Depreciation
- 5
- 4
- Tax %
- 0
- Net Profit
- 4
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
TTM
- 143
- 134
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 4
- Depreciation
- 6
- 8
- Tax %
- -2
- Net Profit
- 8
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 0%
- 5 Years:
- 28%
- 3 Years:
- 20%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- -4%
- 5 Years:
- —
- 3 Years:
- -7%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 30%
- 1 Year:
- 129%
RETURN ON EQUITY
- 10 Years:
- -12%
- 5 Years:
- 12%
- 3 Years:
- 10%
- Last Year:
- 5%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 19 | 19 | 24 | 24 | 2 | 24 | 24 | 24 | 24 | 24 |
| 41 | 22 | 17 | -3 | -7 | 33 | 38 | 50 | 57 | 61 | |
| 45 | 43 | 23 | 23 | 0 | 10 | 6 | 14 | 10 | 9 | |
| Trade Payables | 30 | 23 | 28 | 39 | 13 | 11 | 12 | 28 | 35 | 31 |
| 50 | 59 | 36 | 37 | 63 | 9 | 10 | 13 | 21 | 29 | |
| Total Liabilities | 185 | 167 | 128 | 121 | 71 | 86 | 90 | 130 | 148 | 153 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 47 | 43 | 40 | 37 | 35 | 36 | 39 | 40 | 40 | 59 | |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 10 | 7 |
| 18 | 18 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 16 | 17 | 11 | 9 | 11 | 15 | 20 | 22 | 30 | 28 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45 | 40 | |
| Cash & Bank | 3 | 3 | 3 | 3 | 8 | 2 | 0 | 8 | 1 | 3 |
| 101 | 86 | 73 | 70 | 16 | 32 | 31 | 59 | 21 | 15 | |
| Total Assets | 185 | 167 | 128 | 121 | 71 | 86 | 90 | 130 | 148 | 153 |
| Total Debt | 80 | 82 | 47 | 46 | 3 | 13 | 11 | 23 | 24 | 28 |
| Net Working Capital | 32 | -4 | -11 | -22 | 19 | 25 | 29 | 41 | 40 | 33 |
| Contingent Liabilities | 3 | 0 | 0 | 0 | 5 | 2 | 6 | 10 | 18 | 18 |
| Book Value per Share | 31.48 | 21.96 | 17.13 | 8.79 | -18.64 | 24.00 | 26.19 | 31.05 | 34.17 | 35.85 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 80 | 82 | 47 | 46 | 3 | 13 | 11 | 23 | 24 | 28 |
| Net Working Capital | 32 | -4 | -11 | -22 | 19 | 25 | 29 | 41 | 40 | 33 |
| Contingent Liabilities | 3 | 0 | 0 | 0 | 5 | 2 | 6 | 10 | 18 | 18 |
| Book Value per Share | 31.48 | 21.96 | 17.13 | 8.79 | -18.64 | 24.00 | 26.19 | 31.05 | 34.17 | 35.85 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- Equity Capital
- 19
- 41
- 45
- Trade Payables
- 30
- 50
- Total Liabilities
- 185
- 47
- Capital Work in Progress
- 0
- 18
- 16
- 0
- Cash & Bank
- 3
- 101
- Total Assets
- 185
- Total Debt
- 80
- Net Working Capital
- 32
- Contingent Liabilities
- 3
- Book Value per Share
- 31.48
- Face Value
- 10.00
- Total Debt
- 80
- Net Working Capital
- 32
- Contingent Liabilities
- 3
- Book Value per Share
- 31.48
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 19
- 22
- 43
- Trade Payables
- 23
- 59
- Total Liabilities
- 167
- 43
- Capital Work in Progress
- 0
- 18
- 17
- 0
- Cash & Bank
- 3
- 86
- Total Assets
- 167
- Total Debt
- 82
- Net Working Capital
- -4
- Contingent Liabilities
- 0
- Book Value per Share
- 21.96
- Face Value
- 10.00
- Total Debt
- 82
- Net Working Capital
- -4
- Contingent Liabilities
- 0
- Book Value per Share
- 21.96
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 24
- 17
- 23
- Trade Payables
- 28
- 36
- Total Liabilities
- 128
- 40
- Capital Work in Progress
- 0
- 1
- 11
- 0
- Cash & Bank
- 3
- 73
- Total Assets
- 128
- Total Debt
- 47
- Net Working Capital
- -11
- Contingent Liabilities
- 0
- Book Value per Share
- 17.13
- Face Value
- 10.00
- Total Debt
- 47
- Net Working Capital
- -11
- Contingent Liabilities
- 0
- Book Value per Share
- 17.13
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 24
- -3
- 23
- Trade Payables
- 39
- 37
- Total Liabilities
- 121
- 37
- Capital Work in Progress
- 0
- 1
- 9
- 0
- Cash & Bank
- 3
- 70
- Total Assets
- 121
- Total Debt
- 46
- Net Working Capital
- -22
- Contingent Liabilities
- 0
- Book Value per Share
- 8.79
- Face Value
- 10.00
- Total Debt
- 46
- Net Working Capital
- -22
- Contingent Liabilities
- 0
- Book Value per Share
- 8.79
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 2
- -7
- 0
- Trade Payables
- 13
- 63
- Total Liabilities
- 71
- 35
- Capital Work in Progress
- 0
- 0
- 11
- 0
- Cash & Bank
- 8
- 16
- Total Assets
- 71
- Total Debt
- 3
- Net Working Capital
- 19
- Contingent Liabilities
- 5
- Book Value per Share
- -18.64
- Face Value
- 10.00
- Total Debt
- 3
- Net Working Capital
- 19
- Contingent Liabilities
- 5
- Book Value per Share
- -18.64
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 24
- 33
- 10
- Trade Payables
- 11
- 9
- Total Liabilities
- 86
- 36
- Capital Work in Progress
- 1
- 0
- 15
- 0
- Cash & Bank
- 2
- 32
- Total Assets
- 86
- Total Debt
- 13
- Net Working Capital
- 25
- Contingent Liabilities
- 2
- Book Value per Share
- 24.00
- Face Value
- 10.00
- Total Debt
- 13
- Net Working Capital
- 25
- Contingent Liabilities
- 2
- Book Value per Share
- 24.00
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 24
- 38
- 6
- Trade Payables
- 12
- 10
- Total Liabilities
- 90
- 39
- Capital Work in Progress
- 0
- 0
- 20
- 0
- Cash & Bank
- 0
- 31
- Total Assets
- 90
- Total Debt
- 11
- Net Working Capital
- 29
- Contingent Liabilities
- 6
- Book Value per Share
- 26.19
- Face Value
- 10.00
- Total Debt
- 11
- Net Working Capital
- 29
- Contingent Liabilities
- 6
- Book Value per Share
- 26.19
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 24
- 50
- 14
- Trade Payables
- 28
- 13
- Total Liabilities
- 130
- 40
- Capital Work in Progress
- 0
- 0
- 22
- 0
- Cash & Bank
- 8
- 59
- Total Assets
- 130
- Total Debt
- 23
- Net Working Capital
- 41
- Contingent Liabilities
- 10
- Book Value per Share
- 31.05
- Face Value
- 10.00
- Total Debt
- 23
- Net Working Capital
- 41
- Contingent Liabilities
- 10
- Book Value per Share
- 31.05
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 24
- 57
- 10
- Trade Payables
- 35
- 21
- Total Liabilities
- 148
- 40
- Capital Work in Progress
- 10
- 0
- 30
- 45
- Cash & Bank
- 1
- 21
- Total Assets
- 148
- Total Debt
- 24
- Net Working Capital
- 40
- Contingent Liabilities
- 18
- Book Value per Share
- 34.17
- Face Value
- 10.00
- Total Debt
- 24
- Net Working Capital
- 40
- Contingent Liabilities
- 18
- Book Value per Share
- 34.17
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 24
- 61
- 9
- Trade Payables
- 31
- 29
- Total Liabilities
- 153
- 59
- Capital Work in Progress
- 7
- 0
- 28
- 40
- Cash & Bank
- 3
- 15
- Total Assets
- 153
- Total Debt
- 28
- Net Working Capital
- 33
- Contingent Liabilities
- 18
- Book Value per Share
- 35.85
- Face Value
- 10.00
- Total Debt
- 28
- Net Working Capital
- 33
- Contingent Liabilities
- 18
- Book Value per Share
- 35.85
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -3 | 20 | -7 | -1 | -34 | -14 | 10 | 5 | 9 | 22 | |
| Cash from Investing | -1 | -14 | 38 | 4 | 33 | -5 | -7 | -7 | -15 | -21 |
| Cash from Financing | 4 | -5 | -31 | -2 | 7 | 12 | -5 | 10 | -1 | 1 |
| 0 | -0 | 0 | -0 | 6 | -7 | -2 | 8 | -6 | 2 | |
| Free Cash Flow | -5 | 20 | -7 | -1 | -36 | -20 | 2 | -2 | -6 | 19 |
| OCF / Net Profit | 0.24 | -1.07 | 0.43 | 0.06 | 18.25 | -2.34 | 1.86 | 0.44 | 1.29 | 5.33 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -30 | -44 | -62 | -56 | -61 | -6 |
| OCF / Net Profit | 0.24 | -1.07 | 0.43 | 0.06 | 18.25 | -2.34 | 1.86 | 0.44 | 1.29 | 5.33 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -30 | -44 | -62 | -56 | -61 | -6 |
Mar 2016
- -3
- Cash from Investing
- -1
- Cash from Financing
- 4
- 0
- Free Cash Flow
- -5
- OCF / Net Profit
- 0.24
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.24
- Cumulative 5-Year FCF
- 0
Mar 2017
- 20
- Cash from Investing
- -14
- Cash from Financing
- -5
- -0
- Free Cash Flow
- 20
- OCF / Net Profit
- -1.07
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.07
- Cumulative 5-Year FCF
- 0
Mar 2018
- -7
- Cash from Investing
- 38
- Cash from Financing
- -31
- 0
- Free Cash Flow
- -7
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
Mar 2019
- -1
- Cash from Investing
- 4
- Cash from Financing
- -2
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- 0
Mar 2020
- -34
- Cash from Investing
- 33
- Cash from Financing
- 7
- 6
- Free Cash Flow
- -36
- OCF / Net Profit
- 18.25
- Cumulative 5-Year FCF
- -30
- OCF / Net Profit
- 18.25
- Cumulative 5-Year FCF
- -30
Mar 2021
- -14
- Cash from Investing
- -5
- Cash from Financing
- 12
- -7
- Free Cash Flow
- -20
- OCF / Net Profit
- -2.34
- Cumulative 5-Year FCF
- -44
- OCF / Net Profit
- -2.34
- Cumulative 5-Year FCF
- -44
Mar 2022
- 10
- Cash from Investing
- -7
- Cash from Financing
- -5
- -2
- Free Cash Flow
- 2
- OCF / Net Profit
- 1.86
- Cumulative 5-Year FCF
- -62
- OCF / Net Profit
- 1.86
- Cumulative 5-Year FCF
- -62
Mar 2023
- 5
- Cash from Investing
- -7
- Cash from Financing
- 10
- 8
- Free Cash Flow
- -2
- OCF / Net Profit
- 0.44
- Cumulative 5-Year FCF
- -56
- OCF / Net Profit
- 0.44
- Cumulative 5-Year FCF
- -56
Mar 2024
- 9
- Cash from Investing
- -15
- Cash from Financing
- -1
- -6
- Free Cash Flow
- -6
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- -61
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- -61
Mar 2025
- 22
- Cash from Investing
- -21
- Cash from Financing
- 1
- 2
- Free Cash Flow
- 19
- OCF / Net Profit
- 5.33
- Cumulative 5-Year FCF
- -6
- OCF / Net Profit
- 5.33
- Cumulative 5-Year FCF
- -6
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | -6.53 | -9.90 | -6.95 | -8.34 | -7.94 | 2.46 | 2.21 | 4.79 | 3.11 | 1.76 |
| Book Value (₹) | 31.48 | 21.96 | 17.13 | 8.79 | -18.64 | 24.00 | 26.19 | 31.05 | 34.17 | 35.85 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | -4.33 | -7.81 | -5.41 | -6.89 | 5.87 | 4.36 | 4.53 | 7.05 | 5.22 | 3.82 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 4.70% | -6.15% | -8.11% | -29.07% | 3.49% | 15.51% | 16.04% | 16.46% | 7.29% | 7.46% |
| Net Margin % | -14.10% | -27.85% | -34.88% | -45.23% | -4.42% | 8.18% | 6.13% | 9.83% | 4.82% | 2.85% |
| ROE % | -18.69% | -37.05% | -40.37% | -64.36% | -22.93% | 22.26% | 8.79% | 16.75% | 9.52% | 5.01% |
| ROCE % | -0.04% | -5.98% | -6.97% | -20.90% | -2.95% | 10.62% | 8.42% | 16.12% | 9.56% | 6.31% |
| -6.58% | -10.49% | -11.17% | -15.90% | -1.96% | 7.40% | 5.91% | 10.32% | 5.30% | 2.76% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 319 | 335 | 302 | 205 | 133 | 40 | 52 | 88 | 104 | 107 |
| Inventory Days | 67 | 91 | 106 | 83 | 89 | 69 | 77 | 67 | 62 | 72 |
| Payable Days | 191 | 197 | 280 | 513 | 586 | 134 | 106 | 118 | 134 | 150 |
| 195 | 229 | 127 | -224 | -365 | -25 | 23 | 37 | 31 | 30 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.37x | 2.01x | 1.15x | 2.22x | -0.68x | 0.23x | 0.18x | 0.31x | 0.30x | 0.33x |
| Interest Coverage (x) | -0.00x | -0.70x | -1.10x | -7.57x | -18.66x | 8.85x | 7.57x | 6.70x | 4.21x | 2.52x |
| 1.37x | 0.95x | 0.82x | 0.68x | 2.10x | 2.04x | 2.31x | 1.88x | 1.73x | 1.63x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -40.14% | -23.86% | -27.39% | -7.51% | -2.65% | 67.68% | 19.55% | 35.48% | 32.18% | -4.33% |
| Operating Profit Growth % | -84.67% | -200.46% | 6.20% | -231.59% | 111.70% | 644.34% | 23.66% | 39.00% | -22.93% | -4.88% |
| Net Profit Growth % | -299.50% | -51.59% | 10.93% | -19.94% | 90.48% | 410.26% | -10.47% | 117.34% | -35.19% | -43.49% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -35.19% | -43.49% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 24.68x | 42.73x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.24x | 2.09x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 13.96x | 14.53x |
Mar 2016
- EPS (₹)
- -6.53
- Book Value (₹)
- 31.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -4.33
- Operating Margin %
- 4.70%
- Net Margin %
- -14.10%
- ROE %
- -18.69%
- ROCE %
- -0.04%
- -6.58%
- Debtor Days
- 319
- Inventory Days
- 67
- Payable Days
- 191
- 195
- Debt to Equity (x)
- 1.37x
- Interest Coverage (x)
- -0.00x
- 1.37x
- Revenue Growth %
- -40.14%
- Operating Profit Growth %
- -84.67%
- Net Profit Growth %
- -299.50%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- -9.90
- Book Value (₹)
- 21.96
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -7.81
- Operating Margin %
- -6.15%
- Net Margin %
- -27.85%
- ROE %
- -37.05%
- ROCE %
- -5.98%
- -10.49%
- Debtor Days
- 335
- Inventory Days
- 91
- Payable Days
- 197
- 229
- Debt to Equity (x)
- 2.01x
- Interest Coverage (x)
- -0.70x
- 0.95x
- Revenue Growth %
- -23.86%
- Operating Profit Growth %
- -200.46%
- Net Profit Growth %
- -51.59%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- -6.95
- Book Value (₹)
- 17.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -5.41
- Operating Margin %
- -8.11%
- Net Margin %
- -34.88%
- ROE %
- -40.37%
- ROCE %
- -6.97%
- -11.17%
- Debtor Days
- 302
- Inventory Days
- 106
- Payable Days
- 280
- 127
- Debt to Equity (x)
- 1.15x
- Interest Coverage (x)
- -1.10x
- 0.82x
- Revenue Growth %
- -27.39%
- Operating Profit Growth %
- 6.20%
- Net Profit Growth %
- 10.93%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- -8.34
- Book Value (₹)
- 8.79
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -6.89
- Operating Margin %
- -29.07%
- Net Margin %
- -45.23%
- ROE %
- -64.36%
- ROCE %
- -20.90%
- -15.90%
- Debtor Days
- 205
- Inventory Days
- 83
- Payable Days
- 513
- -224
- Debt to Equity (x)
- 2.22x
- Interest Coverage (x)
- -7.57x
- 0.68x
- Revenue Growth %
- -7.51%
- Operating Profit Growth %
- -231.59%
- Net Profit Growth %
- -19.94%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -7.94
- Book Value (₹)
- -18.64
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.87
- Operating Margin %
- 3.49%
- Net Margin %
- -4.42%
- ROE %
- -22.93%
- ROCE %
- -2.95%
- -1.96%
- Debtor Days
- 133
- Inventory Days
- 89
- Payable Days
- 586
- -365
- Debt to Equity (x)
- -0.68x
- Interest Coverage (x)
- -18.66x
- 2.10x
- Revenue Growth %
- -2.65%
- Operating Profit Growth %
- 111.70%
- Net Profit Growth %
- 90.48%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 2.46
- Book Value (₹)
- 24.00
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.36
- Operating Margin %
- 15.51%
- Net Margin %
- 8.18%
- ROE %
- 22.26%
- ROCE %
- 10.62%
- 7.40%
- Debtor Days
- 40
- Inventory Days
- 69
- Payable Days
- 134
- -25
- Debt to Equity (x)
- 0.23x
- Interest Coverage (x)
- 8.85x
- 2.04x
- Revenue Growth %
- 67.68%
- Operating Profit Growth %
- 644.34%
- Net Profit Growth %
- 410.26%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 2.21
- Book Value (₹)
- 26.19
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.53
- Operating Margin %
- 16.04%
- Net Margin %
- 6.13%
- ROE %
- 8.79%
- ROCE %
- 8.42%
- 5.91%
- Debtor Days
- 52
- Inventory Days
- 77
- Payable Days
- 106
- 23
- Debt to Equity (x)
- 0.18x
- Interest Coverage (x)
- 7.57x
- 2.31x
- Revenue Growth %
- 19.55%
- Operating Profit Growth %
- 23.66%
- Net Profit Growth %
- -10.47%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 4.79
- Book Value (₹)
- 31.05
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.05
- Operating Margin %
- 16.46%
- Net Margin %
- 9.83%
- ROE %
- 16.75%
- ROCE %
- 16.12%
- 10.32%
- Debtor Days
- 88
- Inventory Days
- 67
- Payable Days
- 118
- 37
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 6.70x
- 1.88x
- Revenue Growth %
- 35.48%
- Operating Profit Growth %
- 39.00%
- Net Profit Growth %
- 117.34%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 3.11
- Book Value (₹)
- 34.17
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.22
- Operating Margin %
- 7.29%
- Net Margin %
- 4.82%
- ROE %
- 9.52%
- ROCE %
- 9.56%
- 5.30%
- Debtor Days
- 104
- Inventory Days
- 62
- Payable Days
- 134
- 31
- Debt to Equity (x)
- 0.30x
- Interest Coverage (x)
- 4.21x
- 1.73x
- Revenue Growth %
- 32.18%
- Operating Profit Growth %
- -22.93%
- Net Profit Growth %
- -35.19%
- -35.19%
- P/E (x)
- 24.68x
- P/B (x)
- 2.24x
- Dividend Yield %
- 0.00%
- 13.96x
Mar 2025
- EPS (₹)
- 1.76
- Book Value (₹)
- 35.85
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.82
- Operating Margin %
- 7.46%
- Net Margin %
- 2.85%
- ROE %
- 5.01%
- ROCE %
- 6.31%
- 2.76%
- Debtor Days
- 107
- Inventory Days
- 72
- Payable Days
- 150
- 30
- Debt to Equity (x)
- 0.33x
- Interest Coverage (x)
- 2.52x
- 1.63x
- Revenue Growth %
- -4.33%
- Operating Profit Growth %
- -4.88%
- Net Profit Growth %
- -43.49%
- -43.49%
- P/E (x)
- 42.73x
- P/B (x)
- 2.09x
- Dividend Yield %
- 0.00%
- 14.53x
Documents
Announcements
- Shareholders meeting
2026-08-19 - Bafna Pharmaceuticals Limited has informed the Exchange regarding Notice of 31st Annual General Meeting of the Company to be held on September 11, 2026 along with the Annual Report for F.Y 2025-2026
- Copy of Newspaper Publication
2026-08-14 - Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026 as published in ''Business Standard'' and ''Makkal Kural'' on August 13, 2026
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.